Archive

2007, Vol. 117, No. 5-6

May 01, 2007

previous issuenext issue
Editorials
Should we PCI in patients with silent myocardial ischemia?

C. Richard Conti

Pol Arch Intern Med. 2007, Vol. 117, No. 5-6: 205-206 / DOI: 10.20452/pamw.128

The role of clopidogrel in cardiovascular diseases

Paul A. Gurbel, Udaya S. Tantry

Pol Arch Intern Med. 2007, Vol. 117, No. 5-6: 207-209 / DOI: 10.20452/pamw.130

Should we give a PPI IV before endoscopy in patients with upper GI bleeding?

Grigoris I. Leontiadis, Efstratios Maltezos, Colin Howden

Pol Arch Intern Med. 2007, Vol. 117, No. 5-6: 210-212 / DOI: 10.20452/pamw.132

Original articles
Arterial stiffness in hypopituitary patients with life-long growth hormone deficiency

Jerzy Kosowicz, Ziad El Ali, Andrzej Wykrętowicz, Tomasz Krauze, Przemysław Guzik

Pol Arch Intern Med. 2007, Vol. 117, No. 5-6: 221-226 / DOI: 10.20452/pamw.136

Effect of elevated bilirubin levels on the long-term outcome in patients with chronic heart failure due to hypertension

Bożena Szyguła-Jurkiewicz, Romuald Wojnicz, Andrzej Lekston, Agata Duszańska, Beata Spinczyk, Jolanta Nowak, Tomasz Niklewski, Krzysztof Halewski, Lech Poloński

Pol Arch Intern Med. 2007, Vol. 117, No. 5-6: 227-233 / DOI: 10.20452/pamw.138

Antiplatelet effects of micronized fenofibrate in subjects with dyslipidemia

Anetta Undas, Magdalena Celińska-Löwenhoff

Pol Arch Intern Med. 2007, Vol. 117, No. 5-6: 235-240 / DOI: 10.20452/pamw.140

Assessment of plasminogen activator inhibitor-1 and von Willebrand factor as a marers of endothelial function in patients with end-stage kidney disease after allotransplantation during a one-year follow-up

Witold Doroszewski, Zbigniew Włodarczyk, Paweł Stróżecki, Jacek Manitius, Ewa Grabarczyk, Danuta Rość, Grażyna Odrowąż-Sypniewska

Pol Arch Intern Med. 2007, Vol. 117, No. 5-6: 313-220 / DOI: 10.20452/pamw.134

Review articles
Acquired haemophilia

Anna Buczma, Jerzy Windyga

Pol Arch Intern Med. 2007, Vol. 117, No. 5-6: 241-245 / DOI: 10.20452/pamw.142

Clinical significance of interleukin-6 (IL-6) as a prognostic factor of cancer disease

Marta Łukaszewicz, Barbara Mroczko, Maciej Szmitkowski

Pol Arch Intern Med. 2007, Vol. 117, No. 5-6: 247-251 / DOI: 10.20452/pamw.144

Postprandial glycemia – review of current pathophysioogical, epidemiological and clinical aspects

Krzysztof Strojek, Liliana Majkowska, Dorota Zozulińska, Janusz Gumprecht, Janusz Krzymień, Maciej Małecki

Pol Arch Intern Med. 2007, Vol. 117, No. 5-6: 252-259 / DOI: 10.20452/pamw.146

Case reports
Clinical stability of Fabry disease in 54 months’ enzyme replacement therapy – follow-up of the first Polish study

Stanisława Bazan-Socha, Tomasz Miszalski-Jamka, Paweł Petkow-Dimitrow, Jacek Musiał

Pol Arch Intern Med. 2007, Vol. 117, No. 5-6: 260-265 / DOI: 10.20452/pamw.148

Progressive hearing loss as the leading sign of Wegener’s granulomatosis

Marcin Grzegorz Dębski, Katarzyna Życińska, Marek Czarkowski, Małgorzata Żukowska, Kazimierz A. Wardyn, Ewa Bar-Andziak

Pol Arch Intern Med. 2007, Vol. 117, No. 5-6: 266-269 / DOI: 10.20452/pamw.150

History of internal medicine in Poland
Władysław Antoni Gluziński – an eminent Polish internist, founder of the Polish Society of Internal Medicine

Eugeniusz Józef Kucharz

Pol Arch Intern Med. 2007, Vol. 117, No. 5-6: 270-273 / DOI: 10.20452/pamw.152

Impact Factor 2022

4.8

IC value for 2022

217.18

Ministry of Education and Science score

200
Average times from:
submission to 1st decision, 2 days
submission to first reviews, 23 days
acceptance to online first publication, 7 days
acceptance to final publication, 91 days

Current manuscript acceptance rate: 28%
The journal is co-financed from the state budget under the "Development of scientific journals" program of the Ministry of Education and Science in the years 2022-2024. Read more